Daytime Systolic Ambulatory Blood Pressure With a Two-Step Switch From Candesartan to Olmesartan Monotherapy and the Fixed-Dose Combination of Olmesartan/Amlodipine in Patients With Uncontrolled Essential Hypertension (SEVICONTROL-2)

  • Peter Bramlage, Claudia Zemmrich, Andrea Gansz, Claus-Dieter Sturm, Rolf Fimmers, Jennifer Nadal, Roland E. Schmieder, Joachim Schrader, Stephan Lüders
  • Journal of Clinical Hypertension, November 2013, Wiley
  • DOI: 10.1111/jch.12227

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Peter Bramlage